Acetaminophen and Diphenhydramine Only Product for Idiopathic Thrombocytopenic Purpura
Study Summary
This trial will test if it's possible to enroll children with ITP who are receiving IVIG for treatment, and if they're willing to participate in a scheduled medication regimen. They will also test if patients and families are able to stick to the schedule.
- Idiopathic Thrombocytopenic Purpura (ITP)
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 5 Secondary · Reporting Duration: 12 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Scheduled post-IVIG medication
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Acetaminophen and Diphenhydramine Only Product · No Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 1 - 18 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are senior citizens eligible to take part in this clinical trial?
"According to the medical trial's requirements, patients wishing to be enrolled must have a minimum age of 1 Month and maximum age of 18." - Anonymous Online Contributor
For what maladies is Acetaminophen and Diphenhydramine Only Product commonly prescribed?
"Acetaminophen and Diphenhydramine Only Product is a prescribed medication utilized to relieve pain, catarrh, and rhinorrhoea." - Anonymous Online Contributor
Are applications for this investigation still being received?
"As of now, the clinical trial hosted on clinicialtrials.gov is recruiting patients and has been since October 20th 2021. The latest update to the study came in April 11th 2022." - Anonymous Online Contributor
Has the Acetaminophen and Diphenhydramine combination been certified by the FDA?
"The safety of Acetaminophen and Diphenhydramine Only Product is assessed at a 1 as this is an early stage clinical trial. There are minimal data points indicating its efficacy or risk profile." - Anonymous Online Contributor
What is the total number of research subjects involved in this experiment?
"Affirmative. The clinicaltrial.gov portal has documented that this trial, which was initially listed on October 20th 2021, is actively enrolling patients. Approximately 20 people are needed from one medical facility to participate in the study." - Anonymous Online Contributor
Who is eligible to participate in this experimental venture?
"Presently, this trial is accepting 20 sufferers of thrombocytopenia aged 1 Month to 18. All participants must have a confirmed diagnosis from the haematology team and be undergoing IVIG treatment as prescribed by their primary care provider, regardless if it was given in an outpatient or emergency setting." - Anonymous Online Contributor
What prior research has been undertaken on the effects of Acetaminophen and Diphenhydramine Only Product?
"At present, there are 104 studies concerning the combination of Acetaminophen and Diphenhydramine Only Product. Of these trials, 30 have moved into Phase 3. In addition to Taichung, Florida, over a thousand sites around the world are currently running research for this particular product." - Anonymous Online Contributor